Arrowstreet Capital
CLMT icon

Arrowstreet Capital’s Calumet Specialty Products CLMT Stock Holding History

Arrowstreet Capital’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23,500
Closed -$143K – 1923
2021
Q1 		$143K Buy
+23,500
New +$98.1K ﹤0.01% 2167
2018
Q1 		– Sell
-11,500
Closed -$89K – 1145
2017
Q4 		$89K Buy
+11,500
New +$95.9K ﹤0.01% 1211

Other funds holding CLMT

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SCM
Springhouse Capital Management Westport, Connecticut $55.3M AUM 20.84% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return
WWM
Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital's CLMT Position: Q2 2021 in Review

Arrowstreet Capital sold out of Calumet Specialty Products (CLMT) in Q2 2021, closing a stake of 23,500 shares — an estimated $143K sold.

Arrowstreet Capital first reported a position in CLMT in Q4 2017 and held it in 2 quarters. The position peaked at $143K in Q1 2021. 65 funds tracked by Wall St. Rank hold CLMT as of Q2 2021.

  • Arrowstreet Capital reported no remaining Calumet Specialty Products position as of Q2 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 23,500 Calumet Specialty Products shares in Q2 2021, an estimated $143K.
  • Arrowstreet Capital first reported a position in Calumet Specialty Products in Q4 2017 and held it in 2 quarters.
  • Arrowstreet Capital's Calumet Specialty Products position peaked at $143K in Q1 2021.
  • 65 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2021.

Based on Arrowstreet Capital's 13F filing for Q2 2021, filed 13 Aug 2021.